A Study to Evaluate Quality of Life in Patients Switched to Solifenacin From Other Antimuscarinics

NCT02087098 · clinicaltrials.gov ↗

COMPLETED

Status

2000

Enrollment

INDUSTRY

Sponsor class

Conditions

Urinary Bladder, Overactive

Interventions

DRUG: Solifenacin

Sponsor

Astellas Pharma Europe B.V.